HealthKelun Reports Longer Survival With Sac-TMT in Final OS Analysis of OptiTROP-Lung04By Naomi CalderOct 25, 2026, 11:21 AM UTC
HealthPhase 2 Trial Reports Responses Across 25 Pneumococcal Serotypes for PF-07872412By Naomi CalderOct 24, 2026, 8:25 PM UTC
HealthJohnson & Johnson Reports Early JNJ-6143 Responses in Prostate Cancer TrialBy Naomi CalderOct 24, 2026, 6:21 PM UTC
HealthStudy Links Apalutamide Before and After Surgery to Lower Event HazardBy Naomi CalderOct 24, 2026, 3:21 PM UTC
HealthTrial Links Darolutamide Add-On to 95% Four-Year Metastasis-Free SurvivalBy Naomi CalderOct 24, 2026, 11:40 AM UTC
HealthNovartis Drug Lowers Annualized Relapse Rates by Up to 35.2% in MS TrialsBy Naomi CalderOct 24, 2026, 2:44 AM UTC
HealthBioNTech Plans Pumitamig-Trodelvy Regimen in Breast Cancer TrialBy Naomi CalderOct 24, 2026, 1:47 AM UTC
HealthSun Pharma to Present Long-Term UNLOXCYT Data at ESMO After 205-Patient Study UpdateBy Naomi CalderOct 23, 2026, 11:15 PM UTC
